These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17584097)

  • 1. Platelets and vascular risk: an option for treatment.
    Jagroop IA; Kakafika AI; Mikhailidis DP
    Curr Pharm Des; 2007; 13(16):1669-83. PubMed ID: 17584097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis and antithrombotic therapy in women.
    Bailey AL; Scantlebury DC; Smyth SS
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):284-8. PubMed ID: 19221205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term antiplatelet therapy.
    Papathanasiou AI; Goudevenos JA; Mikhailidis DP; Tselepis AD
    Drugs Today (Barc); 2008 May; 44(5):331-52. PubMed ID: 18548136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet Signaling Pathways and New Inhibitors.
    Grover SP; Bergmeier W; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of platelets in peripheral arterial disease: therapeutic implications.
    Matsagas MI; Geroulakos G; Mikhailidis DP
    Ann Vasc Surg; 2002 Mar; 16(2):246-58. PubMed ID: 11972262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.
    Bae ON
    Arch Pharm Res; 2012 Oct; 35(10):1693-9. PubMed ID: 23139119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of platelet activation-inhibitory drugs.
    Rao GH; Rao AT
    Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 13. Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
    Passacquale G; Ferro A
    Br J Clin Pharmacol; 2011 Oct; 72(4):604-18. PubMed ID: 21223359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel porcine model of thrombotic myocardial infarction with cardiac dysfunction sensitive to dual antiplatelet therapy.
    Mizuno M; Ito Y; Sugidachi A
    Eur J Pharmacol; 2018 Sep; 834():103-108. PubMed ID: 30016661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seminars in thrombosis, thrombolysis and vascular biology. 3. Platelet activity in cardiovascular disease.
    Becker RC
    Cardiology; 1991; 79(1):49-63. PubMed ID: 1777914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
    Natarajan A; Zaman AG; Marshall SM
    Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
    Moshfegh K; Redondo M; Julmy F; Wuillemin WA; Gebauer MU; Haeberli A; Meyer BJ
    J Am Coll Cardiol; 2000 Sep; 36(3):699-705. PubMed ID: 10987587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders.
    Stamler JS; Loscalzo J
    J Am Coll Cardiol; 1991 Nov; 18(6):1529-36. PubMed ID: 1939957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet drugs in cardiovascular diseases.
    Weston C; Rao U
    Int J Clin Pract; 2003 Dec; 57(10):898-905. PubMed ID: 14712893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.